NASDAQ
No price data available for this timeframe.
Eton Pharmaceuticals, Inc. (ETON) has a price/fcf ratio of 44.65x as of Monday, May 25, 2026. This represents a 55.98% decrease compared to its 12-month average of 101.42x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.